With the aim to discover a gastric antisecretory agent more potent than the existing proton pump inhibitors, novel 3,4-dihydro-1H-spiro(naphthalene-2,2'-piperidin)-1-one derivatives, which could occupy two important lipophilic pockets (described as LP-1 and LP-2) of H,K-ATPase and can strongly bind to the K-binding site, were designed based on a docking model. Among the compounds synthesized, compound 4d showed a strong H,K-ATPase-inhibitory activity and a high stomach concentration in rats, resulting in potent inhibitory action on histamine-stimulated gastric acid secretion in rats. Furthermore, 4d exerted significant inhibitory action on histamine-stimulated gastric-acid secretion in rats with a rapid onset and moderate duration of action after the administration. These findings may lead to a new insight into the drug design of potassium-competitive acid blockers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmc.2017.05.012 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!